CSPC Innovation Pharmaceutical Co Ltd Class A (300765) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.009x

Based on the latest financial reports, CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a cash flow conversion efficiency ratio of -0.009x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-25.98 Million ≈ $-3.80 Million USD) by net assets (CN¥2.80 Billion ≈ $409.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

CSPC Innovation Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how CSPC Innovation Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CSPC Innovation Pharmaceutical Co Ltd Cl balance sheet liabilities for a breakdown of total debt and financial obligations.

CSPC Innovation Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CSPC Innovation Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dongxing Sec Co Ltd SHG:601198	-0.113x
Zhejiang Longsheng Group Co Ltd SHG:600352	0.038x
Enel Chile S.A SN:ENELCHILE	41.644x
Ramsay Health Care Ltd AU:RHC	0.207x
Castellum AB ST:CAST	0.018x
Lithia Motors Inc NYSE:LAD	0.024x
Chailease Holding Co Ltd TW:5871	0.057x
Peric Special Gases Co. Ltd. A SHG:688146	N/A

Annual Cash Flow Conversion Efficiency for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2025)

The table below shows the annual cash flow conversion efficiency of CSPC Innovation Pharmaceutical Co Ltd Class A from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see CSPC Innovation Pharmaceutical Co Ltd Cl (300765) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.80 Billion ≈ $409.04 Million	CN¥-195.69 Million ≈ $-28.64 Million	-0.070x	+74.52%
2024-12-31	CN¥4.50 Billion ≈ $657.90 Million	CN¥-1.24 Billion ≈ $-180.73 Million	-0.275x	-262.45%
2023-12-31	CN¥5.48 Billion ≈ $802.37 Million	CN¥927.24 Million ≈ $135.68 Million	0.169x	+4.10%
2022-12-31	CN¥3.94 Billion ≈ $577.16 Million	CN¥640.72 Million ≈ $93.76 Million	0.162x	+83.40%
2021-12-31	CN¥3.30 Billion ≈ $482.55 Million	CN¥292.09 Million ≈ $42.74 Million	0.089x	-31.82%
2020-12-31	CN¥2.69 Billion ≈ $393.18 Million	CN¥349.07 Million ≈ $51.08 Million	0.130x	-0.51%
2019-12-31	CN¥2.42 Billion ≈ $353.44 Million	CN¥315.38 Million ≈ $46.15 Million	0.131x	-18.30%
2018-12-31	CN¥999.35 Million ≈ $146.24 Million	CN¥159.73 Million ≈ $23.37 Million	0.160x	+9327.66%
2017-12-31	CN¥766.93 Million ≈ $112.23 Million	CN¥1.30 Million ≈ $190.26K	0.002x	-99.29%
2016-12-31	CN¥572.02 Million ≈ $83.70 Million	CN¥137.27 Million ≈ $20.09 Million	0.240x	+34.25%
2015-12-31	CN¥626.83 Million ≈ $91.72 Million	CN¥112.05 Million ≈ $16.40 Million	0.179x	+2.85%
2014-12-31	CN¥537.16 Million ≈ $78.60 Million	CN¥93.36 Million ≈ $13.66 Million	0.174x	--

About CSPC Innovation Pharmaceutical Co Ltd Class A

SHE:300765 China Packaged Foods

Market Cap

$6.24 Billion

CN¥42.66 Billion CNY

Market Cap Rank

#3095 Global

#436 in China

Share Price

CN¥30.37

Change (1 day)

+1.44%

52-Week Range

CN¥28.00 - CN¥63.00

All Time High

CN¥189977.21